18 September 2020 : Original article
ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients – Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?
Shih-Chao Hsu123ABCDEF, Ashok Thorat13ABCEF, Long-Bin Jeng143ABCDEF*, Ping-Chun Li135ADF, Te-Hung Chen123BCF, Horng-Ren Yang123BDE, Kin-Shing Poon36DFDOI: 10.12659/AOT.923502
Ann Transplant 2020; 25:e923502
Table 2 Overview of complications in ABOi LDLT study cohort.
| ERA | Complications | Outcome (D/A) | Cause of death (n=9) |
|---|---|---|---|
| I (9) | 1 HAT | 1 HAT | |
| 1 Hepatic necrosis | 1 Hepatic necrosis | ||
| 1 Lymphoma | |||
| 2 HCC | |||
| II (6) | 1 HAT | 1 HAT | |
| 5 Severe infection | 3 Severe infection | ||
| III (50) | 1 AMR | 4 HCC recurrence (1< UCSF, 3> UCSF) | |
| 7 Rejection | 2 Sepsis | ||
| 4 DIHBS | 1 Pulmonary infection and ECMO dysfunction (HCC >UCSF) | ||
| 5 patients had severe infection | 2 Biliary tract infection | ||
| 15 patients had anastomotic biliary strictures | – | ||